Cresco Labs Announces Presentation at the OTC Cannabis Conference on October 30, 2019
Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco" or the "Company"), one of the largest vertically integrated multistate cannabis operators in the United States, today announced Charlie Bachtell, CEO & Co-Founder will present at the OTC Cannabis Conference at 2:30 PM ET on October 30, 2019. To register for the conference and view the presentations, please click here.
The OTC Cannabis Conference, in partnership with the Canadian Securities Exchange (CSE), provides a platform for public cannabis company executives to share their vision and answer questions from individual investors, institutional investors, advisors, and analysts.
About Cresco Labs
Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods ("CPG") approach to cannabis, Cresco's house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi and Mindy's, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside*, Cresco's national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco has launched the industry's first national comprehensive Social Equity and Educational Development (SEED) initiative designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
News published on and distributed by:
